Evolent Health, Inc.
EVH
$23.07
-$0.24-1.03%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 46.76% | 45.26% | 46.99% | 50.01% | 49.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 46.76% | 45.26% | 46.99% | 50.01% | 49.77% |
| Cost of Revenue | 53.49% | 45.20% | 49.73% | 54.12% | 56.53% |
| Gross Profit | 25.49% | 45.45% | 39.23% | 38.75% | 31.79% |
| SG&A Expenses | 13.39% | 25.74% | 26.31% | 25.32% | 22.46% |
| Depreciation & Amortization | 51.96% | 83.66% | 81.78% | 63.56% | 35.71% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.22% | 43.59% | 46.66% | 48.58% | 47.91% |
| Operating Income | 113.52% | 493.28% | 81.77% | 839.40% | 359.64% |
| Income Before Tax | 10.37% | -226.05% | -234.14% | -848.85% | -525.16% |
| Income Tax Expenses | 81.72% | -106.02% | -63.70% | -14,311.89% | -10,599.72% |
| Earnings from Continuing Operations | -231.02% | -504.46% | -2,016.26% | -226.44% | -36.36% |
| Earnings from Discontinued Operations | -- | -- | 100.00% | 100.00% | 94.68% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -226.48% | -489.86% | -575.81% | -121.94% | -1.97% |
| EBIT | 113.52% | 493.28% | 81.77% | 839.40% | 359.64% |
| EBITDA | 85.18% | 179.77% | 124.44% | 146.04% | 131.43% |
| EPS Basic | -224.72% | -531.22% | -573.01% | -116.50% | -0.94% |
| Normalized Basic EPS | 91.90% | -41.69% | -95.76% | -841.92% | -417.25% |
| EPS Diluted | -224.54% | -527.13% | -562.55% | -116.74% | -1.38% |
| Normalized Diluted EPS | 91.77% | -46.76% | -104.19% | -828.19% | -409.30% |
| Average Basic Shares Outstanding | 14.85% | 18.75% | 18.71% | 17.09% | 12.56% |
| Average Diluted Shares Outstanding | 13.69% | 17.49% | 17.41% | 18.22% | 13.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.70% | -- | -- | -- | -- |
